Ascentage Pharma Group International (AAPG) Long-Term Investments (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Long-Term Investments for 3 consecutive years, with $4.7 million as the latest value for Q4 2025.
- For Q4 2025, Long-Term Investments rose 2.25% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $4.7 million, up 2.25%, while the annual FY2025 figure was $4.7 million, 5.38% up from the prior year.
- Long-Term Investments hit $4.7 million in Q4 2025 for Ascentage Pharma Group International, up from $4.6 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $4.7 million in Q4 2025 and bottomed at $2.4 million in Q4 2023.
- Average Long-Term Investments over 3 years is $3.9 million, with a median of $4.6 million recorded in 2024.
- Year-over-year, Long-Term Investments skyrocketed 92.93% in 2024 and then increased 2.25% in 2025.
- Ascentage Pharma Group International's Long-Term Investments stood at $2.4 million in 2023, then surged by 92.93% to $4.6 million in 2024, then grew by 2.25% to $4.7 million in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods came in at $4.7 million, $4.6 million, and $2.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.